Figure 4From: Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring Regional recommendations for using natalizumab in anti-JCV antibody-negative patients. JCV: John Cunningham virus.Back to article page